Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03119090 · ClinicalTrials.gov registry record
Fontan Imaging Biomarkers (FIB) Study
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 200
- Enrollment target
NCT03119090: Completed study, sponsored by Boston Children's Hospital.
NCT03119090 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03119090 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The goal of the Fontan Imaging Biomarkers (FIB) study is to identify the associations of blood and urine biomarkers to imaging parameters of ventricular mechanics.
Primary Outcome
Correlation of biomarkers and imaging parameters of ventricular mechanics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-09 |
| Est. Completion | 2021-07 |
What the finished NCT03119090 record still lists
NCT03119090 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03119090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03119090 about?
NCT03119090 is a clinical study titled "Fontan Imaging Biomarkers (FIB) Study". The goal of the Fontan Imaging Biomarkers (FIB) study is to identify the associations of blood and urine biomarkers to imaging parameters of ventricular mechanics.
What is the current status of trial NCT03119090?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2015-09. Estimated completion is 2021-07.
Who is sponsoring clinical trial NCT03119090?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia